ABUS ARBUTUS BIOPHARMA CORP Other Situations 8-K Filing 2023 - Announcement of Abstract Acceptance Arbutus Biopharma Corp announced that two abstracts have been accepted as late-breaker oral presentations at the Global Hepatitis Summit 2023.Get access to all SEC 8-K filings of the ARBUTUS BIOPHARMA CORP